CD4 and tuberculosis: This assumption was supported by the work of Aagaard et al., who demonstrated that increases in double- (TNF-α and IL-2) or triple-positive (IFN-γ, IL-2 and TNF-α) CD4+ T cells correlated with protection offered by TB vaccine candidates in a mouse model (72).